Skip to main content
. 2019 Feb 22;11(2):93. doi: 10.3390/pharmaceutics11020093

Figure 7.

Figure 7

Cell viability of HEK 293T cells and LO2 cells upon treatment with a series of concentrations of RBGPs (3, 60, 120, 240, 300, 480, 600, 750 μg/mL).